Clinical Trial Details
| Trial ID: | L2249 |
| Source ID: | NCT00348725 |
| Associated Drug: | Fenofibrate And Metformin Fixed Combination (Drug) |
| Title: | Acceptability of a Fixed Combination of Fenofibrate and Metformin |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Dyslipidemia/Glucose Metabolism Disorder |
| Interventions: | DRUG: fenofibrate and metformin fixed combination (drug) |
| Outcome Measures: | Primary: Quotation by Visual Numeric Rating Scale before and after 4-week treatment | Secondary: Assessment of safety by reporting of Adverse Events |
| Sponsor/Collaborators: | Sponsor: Solvay Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 69 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2005-04 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2007-09-03 |
| Locations: | Site 24, Anzin, France|Site 23, Bachant, France|Site 21, Baune, France|Site 32, Bersee, France|Site 34, Briollay, France|Site 27, Denain, France|Site 28, Denain, France|Site 5, Le Temple de Bretagne, France|Site 29, Nantes, France|Site 2, Nantes, France|Site 8, Nantes, France|Site 9, Nantes, France|Site 1, Nort sur Erdre, France|Site 13, Parcay les Pins, France|Site 26, Quarouble, France|Site 7, Saint Aignan le Grand, France|Site 4, Saint Herblain, France|Site 30, Saint-Amand, France|Site 11, Sautron, France|Site 17, Segre, France|Site 10, St Etienne de Montluc, France|Site 33, Thiant, France|Site 12, Thouars, France|Site 25, Vieux Conde, France|Site 20, Vihiers, France |
| URL: | https://clinicaltrials.gov/show/NCT00348725 |
